Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

BACKGROUND: The prognostic biomarker for patients undergoing curative liver metastasectomy for colorectal cancer (CRC) is lacking. The purpose was to investigate the prognostic role of a lack of CDX2 expression, which has been proposed as a potential biomarker for high-risk relapse in early-stage CR...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Shigematsu, Yasuyuki, Inamura, Kentaro, Yamamoto, Noriko, Mise, Yoshihiro, Saiura, Akio, Ishikawa, Yuichi, Takahashi, Shunji, Kanda, Hiroaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192098/
https://ncbi.nlm.nih.gov/pubmed/30326864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4902-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak